Mostrar el registro sencillo del ítem

dc.contributor.authorVillanueva Martin, Gonzalo
dc.contributor.authorAcosta Herrera, Marialbert
dc.contributor.authorKerick, Martin
dc.contributor.authorLópez Isac, Elena
dc.contributor.authorCallejas Rubio, José Luis 
dc.contributor.authorInternational SSc Group
dc.contributor.authorAustralian Scleroderma Interest Group (ASIG)
dc.contributor.authorMartín Ibáñez, Javier
dc.contributor.authorBossini Castillo, Lara María 
dc.date.accessioned2022-11-29T09:35:17Z
dc.date.available2022-11-29T09:35:17Z
dc.date.issued2022-10-12
dc.identifier.citationVillanueva-Martin, G... [et al.]. The Effect of Body Fat Distribution on Systemic Sclerosis. J. Clin. Med. 2022, 11, 6014. [https://doi.org/10.3390/jcm11206014]es_ES
dc.identifier.urihttps://hdl.handle.net/10481/78168
dc.description.abstractObesity contributes to a chronic proinflammatory state, which is a known risk factor to develop immune-mediated diseases. However, its role in systemic sclerosis (SSc) remains to be elucidated. Therefore, we conducted a two-sample mendelian randomization (2SMR) study to analyze the effect of three body fat distribution parameters in SSc. As instrumental variables, we used the allele effects described for single nucleotide polymorphisms (SNPs) in different genomewide association studies (GWAS) for SSc, body mass index (BMI), waist-to-hip ratio (WHR) and WHR adjusted for BMI (WHRadjBMI). We performed local (pHESS) and genome-wide (LDSC) genetic correlation analyses between each of the traits and SSc and we applied several Mendelian randomization (MR) methods (i.e., random effects inverse-variance weight, MR-Egger regression, MR pleiotropy residual sum and outlier method and a multivariable model). Our results show no genetic correlation or causal relationship between any of these traits and SSc. Nevertheless, we observed a negative causal association between WHRadjBMI and SSc, which might be due to the effect of gastrointestinal complications suffered by the majority of SSc patients. In conclusion, reverse causality might be an especially difficult confounding factor to define the effect of obesity in the onset of SSc.es_ES
dc.description.sponsorshipMCIN/AEI RTI2018101332-B-100 IJC2018-038026-I IJC2019-040080-I PRE2019-087586es_ES
dc.description.sponsorship"ERDF A way of making Europe" - European Uniones_ES
dc.description.sponsorshipRed de Investigacion en Inflamacion y Enfermedades Reumaticas (RIER) from Instituto de Salud Carlos III RD16/0012/0013es_ES
dc.description.sponsorshipESF Investing in your futurees_ES
dc.language.isoenges_ES
dc.publisherMDPIes_ES
dc.rightsAtribución 4.0 Internacional*
dc.rights.urihttp://creativecommons.org/licenses/by/4.0/*
dc.subjectSystemic sclerosises_ES
dc.subjectMendelian randomizationes_ES
dc.subjectObesity es_ES
dc.titleThe Effect of Body Fat Distribution on Systemic Sclerosises_ES
dc.typeinfo:eu-repo/semantics/articlees_ES
dc.rights.accessRightsinfo:eu-repo/semantics/openAccesses_ES
dc.identifier.doi10.3390/jcm11206014
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersiones_ES


Ficheros en el ítem

[PDF]

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

Atribución 4.0 Internacional
Excepto si se señala otra cosa, la licencia del ítem se describe como Atribución 4.0 Internacional